Intramural coronary lipid injection induces atheromatous lesions expressing proinflammatory chemokines: Implications for the development of a porcine model of atherosclerosis

Cardiovascular Revascularization Medicine

Volumn 12, Issue 5, 2011, Pages 304-311

  Tellez, Armando ^a   Schuster, David S ^a   Alviar, Carlos ^a   López Berenstein, Gabriel ^b   Sanguino, Angela ^b   Ballantyne, Christie ^c   Perrard, Xiao Yuan Dai ^c   Schulz, Daryl G ^d   Rousselle, Serge ^e   Kaluza, Greg L ^a   Granada, Juan F ^a  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d HOUSTON METHODIST HOSPITAL   (United States)

^e Alizée Pathology ^*  (United States)

Author keywords

Animal model of disease; Coronary atherosclerosis; MCP 1; Porcine model; VEGF

Indexed keywords

LECTIN; LIPID; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROCESSING; STAINING; VASA VASORUM;

ANIMALS; CHEMOKINE CCL2; CHEMOKINES; CHOLESTEROL ESTERS; CHOLESTEROL, DIETARY; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INJECTIONS, INTRA-ARTERIAL; LIPOPROTEINS, LDL; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; RNA, MESSENGER; SUS SCROFA; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80052540419     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2011.03.007     Document Type: Article

References (32)

1. Gerrity R.G., Natarajan R., Nadler J.L., Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001, 50:1654-1665.
2. Gerrity R.G., Naito H.K., Richardson M., Schwartz C.J. Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages. Am J Pathol 1979, 95:775-792.
3. Shi Z.S., Feng L., He X., Ishii A., Goldstine J., Vinters H.V., Vinuela F. Vulnerable plaque in a Swine model of carotid atherosclerosis. AJNR Am J Neuroradiol 2009, 30:469-472.
4. Granada J.F., Moreno P.R., Burke A.P., Schulz D.G., Raizner A.E., Kaluza G.L. Endovascular needle injection of cholesteryl linoleate into the arterial wall produces complex vascular lesions identifiable by intravascular ultrasound: early development in a porcine model of vulnerable plaque. Coron Artery Dis 2005, 16:217-224.
5. Granada J.F., Kaluza G.L., Wilensky R.L., Biedermann B.C., Schwartz R.S., Falk E. Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention 2009, 5:140-148.
6. Busnelli M., Froio A., Bacci M.L., Giunti M., Cerrito M.G., Giovannoni R., Forni M., Gentilini F., Scagliarini A., Deleo G., Benatti C., Leone B.E., Biasi G.M., Lavitrano M. Pathogenetic role of hypercholesterolemia in a novel preclinical model of vascular injury in pigs. Atherosclerosis 2009, 207:384-390.
7. Ferns G.A., Avades T.Y. The mechanisms of coronary restenosis: insights from experimental models. Int J Exp Pathol 2000, 81:63-88.
8. Alviar CL, Tellez A, Wallace-Bradley D, Lopez-Berestein G, Sanguino A, Schulz DG, Builes A, Ballantyne CM, Yang CY, Kaluza GL, Granada JF. Impact of adventitial neovascularisation on atherosclerotic plaque composition and vascular remodelling in a porcine model of coronary atherosclerosis. EuroIntervention;5:981-8.
9. Mintz G.S., Nissen S.E., Anderson W.D., Bailey S.R., Erbel R., Fitzgerald P.J., Pinto F.J., Rosenfield K., Siegel R.J., Tuzcu E.M., Yock P.G. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001, 37:1478-1492.
10. Fan J., Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003, 10:63-71.
11. Frangogiannis N.G. The prognostic value of monocyte chemoattractant protein-1/CCL2 in acute coronary syndromes. J Am Coll Cardiol 2007, 50:2125-2127.
12. Langheinrich A.C., Michniewicz A., Sedding D.G., Walker G., Beighley P.E., Rau W.S., Bohle R.M., Ritman E.L. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice. Arterioscler Thromb Vasc Biol 2006, 26:347-352.
13. Langheinrich A.C., Kampschulte M., Buch T., Bohle R.M. Vasa vasorum and atherosclerosis - Quid novi?. Thromb Haemost 2007, 97:873-879.
14. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
15. Moreno P.R., Purushothaman K.R., Zias E., Sanz J., Fuster V. Neovascularization in human atherosclerosis. Curr Mol Med 2006, 6:457-477.
16. Heil M., Ziegelhoeffer T., Wagner S., Fernandez B., Helisch A., Martin S., Tribulova S., Kuziel W.A., Bachmann G., Schaper W. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 2004, 94:671-677.
17. Ito W.D., Arras M., Winkler B., Scholz D., Schaper J., Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997, 80:829-837.
18. Charo I.F., Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ Res 2004, 95:858-866.
19. Fujii T., Yonemitsu Y., Onimaru M., Tanii M., Nakano T., Egashira K., Takehara T., Inoue M., Hasegawa M., Kuwano H., Sueishi K. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. Arterioscler Thromb Vasc Biol 2006, 26:2483-2489.
20. Hoefer I.E., van Royen N., Buschmann I.R., Piek J.J., Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 2001, 49:609-617.
21. Hartl D., Griese M., Nicolai T., Zissel G., Prell C., Reinhardt D., Schendel D.J., Krauss-Etschmann S. A role for MCP-1/CCR2 in interstitial lung disease in children. Respir Res 2005, 6:93.
22. Takeya M., Yoshimura T., Leonard E.J., Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993, 24:534-539.
23. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura T., Leonard E.J., Witztum J.L., Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991, 88:5252-5256.
24. Inoue S., Egashira K., Ni W., Kitamoto S., Usui M., Otani K., Ishibashi M., Hiasa K., Nishida K., Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 2002, 106:2700-2706.
25. Moulton K.S., Vakili K., Zurakowski D., Soliman M., Butterfield C., Sylvin E., Lo K.M., Gillies S., Javaherian K., Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003, 100:4736-4741.
26. Kolodgie F.D., Narula J., Yuan C., Burke A.P., Finn A.V., Virmani R. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?. J Am Coll Cardiol 2007, 49:2093-2101.
27. von Hundelshausen P., Petersen F., Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 2007, 97:704-713.
28. Matsumoto T., Mugishima H. Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. J Atheroscler Thromb 2006, 13:130-135.
29. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
30. Haft J.I., Haik B.J., Goldstein J.E., Brodyn N.E. Development of significant coronary artery lesions in areas of minimal disease. A common mechanism for coronary disease progression. Chest 1988, 94:731-736.
31. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
32. Mann J.M., Davies M.J. Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation 1996, 94:928-931.